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AbstrAct
Introduction: the majority of parvovirus b19 
infections are asymptomatic. In childhood, 
however, they may present as the fifth disease 
and in adults their manifestations can vary from 
mild, non-specific, cold-like symptoms to other 
forms of presentations. Papular-purpuric gloves 
and socks syndrome (PPGss) is an uncommon 
form of parvovirus b19 infection, characterized 
by symmetric, pruriginous and painful erythema 
and edema of feet and hands. Generally, systemic 
symptoms are usually mild and dissemination 
to other body regions occurs in only 50% of the 
cases. the rash gradually progresses to petechiae 
and purpura delineating well demarcated 
“socks” and “gloves” on both feet and hands. the 
diagnosis is predominantly based on the clinical 
features. serologic conversion is not considered 
as evidence of parvovirus b19 infection and 
histopathological findings from lesional skin 
are not specific. there are no definite antiviral 
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drugs or vaccines against parvovirus. Patients 
with PPGss require only symptomatic therapy. 
case report: We report the case of a 30-year-old 
female with this characteristic erythema caused 
by the parvovirus b19. Nevertheless, this case is 
remarkable because the patient had significant 
systemic manifestations and an exuberant 
perineal and oropharyngeal involvement. 
Further, the erythema assumed a bullous 
expression that has not been so commonly 
reported. A biopsy was performed which was 
unspecific and the diagnosis was confirmed 
with the serology and molecular detection of the 
virus in blood sample as well as on mouth swab. 
Our patient needed treatment to control pain 
and pruritus, fever was self-limited. conclusion: 
A high index of suspicion is essential to diagnose 
patients with this syndrome. Early recognition 
can prevent unproductive measures and the 
good management of this infection.
Keywords: Human parvovirus b19, Parvovirus 
b19 infection, Papular-purpuric socks and gloves 
syndrome, Viral infection
How to cite this article
Burmester I, Santa-Cruz A, Ramalho J, Regadas MJ, 
Gouveia P, Gomes GC, Ângela C, Oliveira N, Mota-
Garcia F, eSilva AO. A case report of papular-purpuric 
gloves and socks syndrome: A manifestation of the 





PEER REviEwEd  |  OPEN A CE S
International Journal of Case Reports and Images, Vol. 7 No. 3, March 2016. ISSN – [0976-3198]
Int J Case Rep Images 2016;7(3):143–148.   
www.ijcasereportsandimages.com
Burmester et al. 144
INtrODUctION
Parvovirus B19 is a small DNA virus of the 
Parvoviridae family that causes a worldwide infection 
[1]. The incubation period varies from 4–21 days and 
usually affects children and young adults [2]. The majority 
of the parvovirus B19 infections are asymptomatic, 
but panoply of manifestations can also occur [3]. In 
childhood, it may manifest itself as the fifth disease, or 
megaloeritema, with a macular-papular erythematous 
rash typically evolving cheeks, trunk and extremities 
[1, 3]. In adulthood the disease can vary from mild, 
non-specific, cold-like symptoms to other uncommon 
presentations like cutaneous manifestations similar to 
children’s rash, hematological disorders such as transient 
aplastic crisis and chronic red cell aplasia, rheumatoid 
manifestations resembling non-erosive polyarthritis and 
also the so-called gloves-socks syndrome, or papular-
purpuric gloves and socks syndrome (PPGSS) [1, 3].
The PPGSS is characterized by symmetric, pruriginous 
and painful erythema and edema of feet and hands that 
gradually evolves to petechiae and purpura, and may 
progress to vesicles and bullae with skin desquamation 
[3, 4]. The rash typically delineates socks and gloves 
involving palms and soles and can also involve other 
areas, such as the perineum region and oral mucosa [3]. 
Systemic symptoms like fever, arthralgias, asthenia and 
anorexia can also accompany this condition [4, 5]. 
The diagnosis is based on the dermatological features 
and confirmed with one of two possible laboratory tests: 
Parvovirus B19-especific antibody testing and viral DNA 
testing [6]. 
There are no specific definite antiviral drugs or 
vaccines against parvovirus. But generally parvovirus 
infection is a self-limited disease that resolves in one to 
three weeks without any treatment [7].
Motivated by the rarity of this syndrome and by the 
unusual presentation in this patient, the authors decided 
to report this case of PPGSS. 
cAsE rEPOrt
A 30-year-old female presented to the emergency 
department complaining of edema and a violaceous, 
painful and very pruriginous exanthema on both hands 
and feet. She described that the rash had begun three 
days before on both soles and progressively extended 
acquiring a socks pattern (Figure 1). Simultaneously, in 
both hands the erythema rapidly assumed gloves forms 
(Figure 2). By the second day, she developed a perineal 
painful erythematous rash also accompanied by a 
greenish leucorrhea as well as began to have fever (38–
39ºC) that responded to antipyretic medication. 
Previous medical history of the patient was 
unremarkable except for an untreated dyslipidemia, a 
spontaneous abortion at the age of 23 and gestational 
diabetes during other pregnancy. Her chronic medication 
included only an oral contraceptive. She had no known 
allergies. Immunizations were in accord to the national 
program. She lived with her husband and her 3-year-old 
son in a suburban area of Portugal and was unemployed. 
She was monogamous with her husband, did not smoke 
or used illicit drugs, did not consume any alcohol, had 
not traveled recently or contact with any diseased person. 
On physical examination, the patient was on a good 
general state of health. She presented symmetrical edema 
and confluent violaceous macules, papules and pustules 
on both sides of her hands and feet with well-defined 
borders delineating “gloves and socks” (Figure 3). The 
exanthema also developed bullae with skin desquamation 
on both soles (Figure 4). The perinea region surface was 
covered with a macular-erythematous and pruritic rash. 
No ulcers were visible and none satellite lymph nodes 
were found. The remainder of the physical examination 
was normal except for the presence of angular cheilitis. 
Laboratory studies showed an elevation of the 
C-reactive protein (170 mg/L) and a decrease of the 
platelets count (127x103/uL). Red and white blood cell 
counts were normal, as well as renal and hepatic function 
tests and electrolytes. She was admitted to the hospital for 
clinical monitoring and further diagnostic investigation. 
Figure 1: Papular-purpuric exanthema and edema evolving 
plants in form of socks. 
International Journal of Case Reports and Images, Vol. 7 No. 3, March 2016. ISSN – [0976-3198]
Int J Case Rep Images 2016;7(3):143–148.  
www.ijcasereportsandimages.com
Burmester et al. 145
Empirical antibiotic therapy with doxycycline was started 
because of the possibility of rickettsiosis, a prevalent 
disease in Portugal.
On the first day of hospitalization she reported a 
sensation of burning mouth and difficulty in chewing and 
swallowing. On the oral exam, the patient had a “pinpoint” 
enanthema dispersed throughout the palate and the jugal 
mucosa (Figure 5). She had no ulcers or petechiaes and 
no involvement of the pharynx or larynx. A swab of the 
enanthem was made for DNA-virus research.
The patient was evaluated by dermatology on the first 
day and a steroid therapy (prednisolone 1 mg/kg per 
day) was started for suspected vasculitis. At that time a 
cutaneous biopsy was performed.  
Additional laboratory studies were requested with 
normal C3 and C4 complement, cryoglobulins and 
protein-electrophoresis. The erythrocyte sedimentation 
rate was 48 mm/h and the immunological study was 
also normal (antinuclear, antineutrophil, anti-DS-
DNA, antiphospholipid and anticardiolipin antibodies). 
Serologic testing for viral hepatitis A, B and C, syphilis, 
rickettsia, Epstein–Barr virus, cytomegalovirus and 
rubella excluded recent infection. HIV serology was 
negative. ELISA tests for herpes virus and for parvovirus 
B19 were positive for IgM and IgG antibodies. The 
presence of parvovirus B19 DNA was then confirmed with 
blood polymerase-chain-reaction (PCR). Enterovirus, 
coxsackie included, were also excluded with PCR. 
Furthermore, the result of the oropharyngeal enanthem 
swab came out two days later and confirmed the 
Figure 2: Papular-purpuric exanthema evolving palms in form 
of gloves.
Figure 3: Details of the palms emphasizing the pustules. 
Figure 4: Details of the exanthema with the formation of bullae. 
Figure 5: “Pinpoint” oropharyngeal enanthema.
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parvovirus B19 infection. The skin biopsy results was not 
specific, and revealed “mild acanthosis and keratinocyte 
apoptosis in the epidermis and  capillary dilatation 
with perivascular infiltrate consisting in lymphocytes, 
histiocytes and eosinophils in the dermis”.
By the time of diagnosis, on the third day of 
hospitalization, the enanthems improved and the patient 
was able to eat. The cutaneous lesions became dryer 
and less pruritic. Doxycycline and prednisolone therapy 
were discontinued. The platelets count returned to 
normal and the C-reactive protein acquired a descending 
profile. Consequently, the patient was discharged home 
only with antihistamine therapy, on the seventh day of 
hospitalization. 
In the follow-up consultation, one month later, a 
complete remission of the lesions on both perineal and 
oropharyngeal enanthems and the normalization of all 
analytical parameters were verified. The patient was able 
to return to her daily life.
DIscUssION
Parvovirus B19 affects mostly children and young 
adults, has a high index of infectivity and is more frequent 
in winter and spring [1]. We report a case occurred on 
spring of a female patient with the PPGSS who had a 
three-year-old boy who recently started attending a 
nursery school. 
The PPGSS in this patient assumed the characteristic 
papular-purpuric pruriginous eruption affecting hands 
and feet. Nevertheless, this case is remarkable because of 
the systemic manifestations and the exuberant perineal 
and oropharyngeal involvement. Generally, systemic 
symptoms are usually mild and patients may experience 
low-grade fever (52%), fatigue (20%), myalgias (16%), 
anorexia (16%), lymphadenopathy (16%) and artralgias 
(12%). Dissemination to other body regions occurs in 
only 50% of the cases [8, 9]. Bullous skin lesions have 
not been so commonly reported [8]. In this case, when 
certain skin areas started to reveal bullae, our concern 
increased towards the possibility of developing Lyell-
like syndrome characteristics or more severe infection 
complications. When the diagnosis was made that risk 
was considered lower since this disease is usually self-
limited with resolution of the exanthema from one to 
three weeks [1, 7, 8]. Very occasionally, especially in 
cases of immunosuppression, the exanthema can persist 
for months [8] or even reappear without any particular 
trigger [10].
The rarity and unfamiliarity with this presentation 
of this disease led us to consider a wide range of 
alternative diagnosis, with multiple tests and exams 
being performed. PPGSS differential diagnosis should 
include other infections with cutaneous involvement, 
vasculitis, hematologic and rheumatic diseases [4]. Other 
viral infections such as Coxsackie B6 virus, human herpes 
virus 6 or 7, hepatitis B, Epstein-Barr, cytomegalovirus, 
measles and rubella virus as well as the Arcanobacterium 
haemolyticum infection have been described as PPGSS 
[4]. Additionally, the trimethoprim/sulfamethoxazole 
[11] can also be related to this syndrome.
The detection of specific immunoglobulin M is helpful 
for the diagnosis. Its peak occurs within the first week, 
declines during the four subsequent weeks [1] and can 
be detectable until three months after infection [3]. 
Immunoglobulin G testing is not useful because it only 
indicates previous infection or immunity [1, 3, 6]. In 
the initial acute phase, the polymerase chain reaction is 
recommended to detect DNA virus, which can be detected 
even with very low viral load [1, 2]. However, normally 
there are no viruses in circulation when the symptoms 
emerge [3]. On average, the viremia period lasts 1 to 2 
days, in general 7–9 days after exposure [1, 6]. 
In this case, IgG and IgM positivity to herpes virus 
and parvovirus B19 were observed. A cross reaction with 
other viruses is frequently found in recent parvovirus B19 
infections, producing false-positive reactions in a variety 
of other infection diseases, specially Herpes virus and 
Epstein–Barr, virus infection [12]. 
As a consequence of a seroprevalence rate of 20–80%, 
in the American and European adult population [1], and 
the cross-reactions for the immunoglobulin M antibody 
class, serologic conversion is not considered as evidence 
of parvovirus B19 infection [8]. In our patient, the 
molecular detection of the virus in blood sample as well as 
on mouth swab strongly supports a causative role of the 
parvovirus B19 in PPGSS. In our hospital, the polymerase 
chain reaction is only qualitative and consequently we did 
not have access to the viral load. Nevertheless, with the 
favorable evolution of our patient and the positivity to the 
parvovirus B19, we thought it was not necessary.
Histopathological findings from skin lesions are not 
specific and therefore they are not useful to diagnose 
PPGSS. Thus, molecular detection of DNA virus in skin 
biopsy can be made, establishing the diagnosis [8].
Patients with PPGSS require only symptomatic 
therapy for fever, pain and pruritus. Corticosteroid 
therapy is not indicated because immunosuppressive 
therapy can promote the persistency of the virus [4]. 
We would like to highlight as particular strengths 
in this case, the epidemiology (seasonability and 
patient’s young child) and the rare but characteristic 
erythema. As limitations we emphasize the extreme 
rarity and unfamiliarity of this syndrome that can lead 
to misdiagnosis due to the huge variety of differential 
diagnosis. The misconduct of this disease can mask the 
clinic, lead to prolongation or even complications of the 
syndrome. In our particular case, the doxycycline and the 
prednisolone therapy could have been avoided if we knew 
the syndrome.
cONcLUsION
A high index of suspicion is essential to diagnose 
patients with this syndrome. Early recognition can prevent 
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